Dr. Dieter Egli, a senior research fellow at the New York Stem Cell Foundation, dives into the fascinating world of somatic cell nuclear transfer (SCNT) and its application in generating embryonic stem cell lines. He shares insights from his groundbreaking research on creating therapeutic cells for diabetes. The conversation also navigates the ethical challenges of egg donation for research and public perceptions surrounding SCNT. Egli's journey highlights both the promising advancements and the complexities inherent in the evolving landscape of stem cell science.